StudyFinds' Dr. Faith Coleman speaks with the doctor testing a new vitamin C treatment that may double the survival time of ...

Cancer is a disease in which mutated cells grow rapidly and uncontrollably. Unfortunately, these cells resist the body’s ...

It has been a long journey for WGN’s Mike Lowe in his cancer fight. In part four of the series, he talks about the road so ...

The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell ...

A groundbreaking study by researchers from RMIT University in Australia and Indian institutions has unveiled a novel ...

A new gold-based drug can slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

Serum lipid profile evaluation significantly improves diagnosis for gastric cancer and predictions for chemotherapy side effect outcomes.

Jemperli plus chemotherapy demonstrated superior overall survival compared to Keytruda in advanced NSCLC, with a median OS of 20.2 months versus 15.9 months. The PERLA trial showed consistent OS ...

Doses are often high, given triple-negative breast cancer's aggressive nature. In the past decade, scientists have searched for alternative treatment options that require lower doses and minimize ...

Aucatzyl is designed to last longer and cause fewer side effects than similar therapies. B-cell ALL affects white blood cells in the bone marrow and spreads to organs like the liver and spleen.